Smith-Magenis syndrome (Ann C. M. Smith)

Related people

A rare condition characterized by distinctive facial features, cognitive impairment with learning difficulties, and behavioral abnormalities.

Description

A rare condition characterized by facial dysmorphy with distinctive facial features progress with age, developmental delay, cognitive impairment with moderate to severe learning difficulties, and behavioural abnormalities including frequent outbursts/temper tantrums, attention seeking and self-injurious behaviours. About 1 in 25,000 children are born with this condition, which us caused by an interstitial deletion of chromosome 17p11.2. In 1986, Ann C. M. Smith and Ruth Ellen Magenis described 9 individuals with a chromosomal deletion at 17p11.2

Bibliography

  • A. C. M. Smith, L. McGavran, G. Waldstein
    Deletion of the 17 short arm in two patients with facial clefts.
    The American Journal of Human Genetics, Chicago, 1982, 34 (Supplement): A410.
  • A. C. M. Smith, L. McGavran, J. Robinson, G. Waldstein, J. Macfarlane, J. Zonana, J. Reiss, M. Lahr, L. Allen, E. Magenis:
    Interstitial deletion of (17)(p11.2p11.2) in nine patients.
    American Journal of Medical Genetics, New York, 1986, 24: 393-414.
  • A. C. Smith, E. Dykens, F. Greenberg:
    Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2).
    American Journal of Medical Genetics, 1998, 81: 179-185.
  • A. C. Smith, E. Dykens, F. Greenberg:
    Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).
    American Journal of Medical Genetics, 1998, 81: 186-191.
  • E. M. Dykens and A. C. Smith:
    Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome.
    Journal of Intellectual Disability Research, Oxford, 1998, 42 (Pt 6): 481-489
  • A. C. Smith, Andrea L. Gropman, Joan E. Bailey-Wilson, Ozlem Goker-Alpan, Sarah H. Elsea, Jan Blancato, James R. Lupski, Lorraine Potocki:
    Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2). Genetics in Medicine, Baltimore, 2002, 4:118-125.
  • A. C. M. Smith, A. K. Leonard, A. Gropman, D. Krasnewich:
    Growth assessment of Smith-Magenis syndrome (abstract).
    54th Annual Meeting of the American Society of Human Genetics, Toronto 2004, page 145.
  • A. C. M. Smith and Wallace C. Duncan:
    Smith-Magenis syndrome: a developmental disorder of circadian dysfunction.
    In: M. G. Butler and F. J. Meaney, editors: Genetics of Developmental Disabilities. Taylor and Francis Group, Boca Raton, 2005.
  • A. C. Smith, R. E, Magenis, S. H. Elsea:
    Overview of Smith-Magenis syndrome.
    Journal of the Association of Genetic Technologists, 2005, 31:163-167.
  • A. C. M. Smith and A. Gropman:
    Smith-Magenis syndrome.
    In: J. Allanson and S. Cassidy, editors: Clinical Management of Common Genetic Syndromes, 2 edition. Wiley-Liss, New York, 2005.
  • A. L. Gropman, W. C. Duncan, A. C. Smith:
    Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Pediatric Neurology, New York, 2006, 34: 337-350.

What is an eponym?

An eponym is a word derived from the name of a person, whether real or fictional. A medical eponym is thus any word related to medicine, whose name is derived from a person.

What is Whonamedit?

Whonamedit.com is a biographical dictionary of medical eponyms. It is our ambition to present a complete survey of all medical phenomena named for a person, with a biography of that person.

Disclaimer:

Whonamedit? does not give medical advice.
This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.